Mostrando resultados 69 a 88 de 91
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | sep-2014 | Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice | Gómez-Sintes, Raquel CSIC ORCID ; Bortolozzi, Analía CSIC ORCID; Artigas, Francesc CSIC ORCID; Lucas, José Javier CSIC ORCID | artículo |
| closedAccess |  | 2004 | Role of tau protein in both physiological and pathological conditions | Ávila, Jesús CSIC ORCID ; Lucas, José Javier CSIC ORCID; Pérez, Mar CSIC ORCID; Hernández, Félix | artículo |
| closedAccess |  | 2002 | Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments | Hernández, Félix; Borrell, José CSIC; Guaza, Carmen CSIC ORCID ; Ávila, Jesús CSIC ORCID ; Lucas, José Javier CSIC ORCID | artículo |
| openAccess |  | 24-feb-2017 | Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury | Engel, Tobías; Martínez-Villareal, Jaime; Henkel, Christine; Jiménez-Mateos, Eva María; Sanz-Rodríguez, Amaya; Alves, Mariana; Hernandez-Santana, Yasmina; Brennan, Gerard P.; Kenny, Aidan; Campbell, Aoife; Lucas, José Javier CSIC ORCID; Henshall, David C. | artículo |
| openAccess |  | 12-abr-2023 | Splice shifting oligonucleotides for use in the treatment of diseases characterized by altered inclusion of microexons | Desviat, Lourdes R. CSIC ORCID; Martínez-Pizarro, Ainhoa; Lucas, José Javier CSIC ORCID; Picó, Sara; Andresen, Brage S. | solicitud de patente |
| openAccess |  | 13-abr-2023 | Splice shifting oligonucleotides for use in the treatment of diseases characterized by altered inclusion of microexons | Desviat, Lourdes R. CSIC ORCID; Martínez-Pizarro, Ainhoa; Lucas, José Javier CSIC ORCID; Picó, Sara; Andresen, Brage S. | solicitud de patente |
| openAccess |  | 2004 | Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 | Bhat, Ratan; Xue, Yafeng; Berg, Stefan; Hellberg, Sven; Ormö, Mats; Nilsson, Yvonne; Radesäter, Ann-Cathrin; Jerning, Eva; Markgren, Per-Olof; Borgegård, Thomas; Nylöf, Martin; Giménez-Cassina, Alfredo; Hernández, Félix; Lucas, José Javier CSIC ORCID; Díaz-Nido, Javier CSIC ORCID; Ávila, Jesús CSIC ORCID | artículo |
| closedAccess |  | 2002 | Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs | Hernández, Félix; Pérez, Mar CSIC ORCID; Lucas, José Javier CSIC ORCID; Ávila, Jesús CSIC ORCID | artículo |
| openAccess |  | 8-jun-2017 | Targeting the proteasome in epilepsy | Engel, Tobías; Lucas, José Javier CSIC ORCID; Henshall, David C. | artículo |
| closedAccess |  | 2004 | Tau in neurodegenerative diseases: Tau phosphorylation and assembly | Ávila, Jesús CSIC ORCID ; Pérez, Mar CSIC ORCID; Lim, Filip CSIC ORCID; Gómez Ramos, Alberto; Hernández, Félix; Lucas, José Javier CSIC ORCID | artículo |
| closedAccess |  | 2010 | Tau kinase I overexpression induces dentate gyrus degeneration | Ávila, Jesús CSIC ORCID ; Gómez de Barreda, Elena CSIC; Engel, Tobías; Pérez, Mar CSIC ORCID; Martín-Maestro, Patricia; Fuster-Matanzo, Almudena CSIC; Goñi-Oliver, Paloma CSIC; Lucas, José Javier CSIC ORCID; Hernández, Félix | artículo |
| closedAccess |  | 2010 | Tau phosphorylation in hippocampus results in toxic gain-of-function | Ávila, Jesús CSIC ORCID ; Gómez de Barreda, Elena CSIC; Engel, Tobías; Lucas, José Javier CSIC ORCID; Hernández, Félix | artículo |
| closedAccess |  | 2010 | Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits | Gómez de Barreda, Elena CSIC; Pérez, Mar CSIC ORCID; Gómez-Ramos, Pilar; Cristobal, Javier de; Martín-Maestro, Patricia; Morán, María A.; Dawson, Hana N.; Vitek, Michael P.; Lucas, José Javier CSIC ORCID; Hernández, Félix; Ávila, Jesús CSIC ORCID | artículo |
| openAccess |  | 2017 | Tau-positive nuclear indentations in P301S tauopathy mice | Fernández-Nogales, Marta CSIC ORCID; Santos-Galindo, María CSIC ORCID; Merchán-Rubira, Jesús; Hoozemans, Jeroen J. M.; Rábano, Alberto; Ferrer, Isidro; Ávila, Jesús CSIC ORCID ; Hernández, Félix; Lucas, José Javier CSIC ORCID | artículo |
| openAccess |  | 2004 | Testing the ubiquitin–proteasome hypothesis of neurodegeneration in vivo | Hernández, Félix; Díaz-Hernández, Miguel; Ávila, Jesús CSIC ORCID ; Lucas, José Javier CSIC ORCID | artículo |
| openAccess |  | 2017 | The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington’s disease | Hernández, Ivó H.; Torres-Peraza, Jesús F. CSIC; Santos-Galindo, Ramós-Morón, Eloisa; Fernández-Fernández, María R.; Pérez-Álvarez, María José CSIC ORCID; Miranda-Vizuete, Antonio CSIC ORCID; Lucas, José Javier CSIC ORCID | artículo |
| closedAccess |  | 2009 | The role of GSK3 in Alzheimer disease | Hernández, Félix; Gómez de Barreda, Elena CSIC; Fuster-Matanzo, Almudena CSIC; Goñi-Oliver, Paloma CSIC; Lucas, José Javier CSIC ORCID; Ávila, Jesús CSIC ORCID | artículo |
| openAccess |  | 2003 | Transgenic mouse models with tau pathology to test therapeutic agents for Alzheimer's disease | Hernández, Félix; Lim, Filip CSIC ORCID; Lucas, José Javier CSIC ORCID; Pérez Martín, María Concepción; Moreno, Francisco J.; Ávila, Jesús CSIC ORCID | artículo |
| openAccess |  | sep-2014 | Ubiquitin-proteasome system involvement in huntington's disease | Ortega, Zaira CSIC; Lucas, José Javier CSIC ORCID | artículo |
| openAccess |  | 25-mar-2021 | Uso combinado de biotina y tiamina en el tratamiento de la enfermedad de Huntington | Lucas, José Javier CSIC ORCID; Picó, Sara; Parras, Alberto; Santos-Galindo, María CSIC ORCID | patente |
